Colon Targeted Guar Gum Compression Coated Tablets of Flurbiprofen: Formulation, Development, and Pharmacokinetics

Abstract EN

The rationale of the present study is to formulate flurbiprofen colon targeted compression coated tablets using guar gum to improve the therapeutic efficacy by increasing drug levels in colon, and also to reduce the side effects in upper gastrointestinal tract.

Direct compression method was used to prepare flurbiprofen core tablets, and they were compression coated with guar gum.

Then the tablets were optimized with the support of in vitro dissolution studies, and further it was proved by pharmacokinetic studies.

The optimized formulation (F4) showed almost complete drug release in the colon (99.86%) within 24 h without drug loss in the initial lag period of 5 h (only 6.84% drug release was observed during this period).

The pharmacokinetic estimations proved the capability of guar gum compression coated tablets to achieve colon targeting.

The Cmax of colon targeted tablets was 11956.15 ng/mL at Tmax of 10 h whereas it was 15677.52 ng/mL at 3 h in case of immediate release tablets.

The area under the curve for the immediate release and compression coated tablets was 40385.78 and 78214.50 ng-h/mL and the mean resident time was 3.49 and 10.78 h, respectively.

In conclusion, formulation of guar gum compression coated tablets was appropriate for colon targeting of flurbiprofen.